Lexology November 22, 2024
Mintz

The PBM regulatory landscape continues to evolve at both the federal and state levels, making it critical for our clients involved in the PBM space to stay apprised of developments in the industry as they happen. Our team actively monitors these developments to provide you with this quarterly PBM Policy and Legislative Update. This update builds on prior issues and highlights federal and state activity from July, August, and September 2024. Activity in this space did slow down a bit over the summer as Congress and state legislators were in recess and stakeholders were generally focused on the election.

Federal Legislative Activity
House Committee on Oversight and Accountability Focuses on PBMs as the Cause of Rising Drug Costs. On July 23,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
Why Walgreens Is Reportedly Considering a Private Equity Buyer
Why 2025 Could Be A Good Reimbursement Year For CVS And Walgreens
PBM reform dropped in Congress' funding package
2025 and Beyond: Key Trends to Watch in Pharmacy
U.S. Health Care Spending Reaches $4.9 Trillion

Share This Article